Not sure about the data?
Download a free 10-row sample first. No account, no payment.
| Company | City | Last round | Amount | Date |
|---|---|---|---|---|
| Pepper | New York | Series C | $50.0M | 2026-02-20 |
| Xona | Burlingame | Series D | $250.0M | 2026-10-22 |
| Suki | Redwood City | Series E | $90.0M | 2026-10-12 |
| RentSpree | Los Angeles | Series B | $17.3M | 2022-08-29 |
| Ocient | Chicago | Series C | $100.0M | 2026-11-05 |
| Modal Labs | New York | Series D | $750.0M | 2026-10-14 |
| BigHat Biosciences | San Mateo | Series C | $75.0M | 2026-09-24 |
| Chptr | New York | Series A | $5.5M | 2026-06-11 |
8 rows of the CSV in 5 of its 18 columns.
- The 302 Gaingels portfolio companies have raised $15.0B in total.
- 24 of them closed their most recent round in the last 12 months, $2.0B combined.
- The largest of those rounds is Modal Labs' $750.0M Series D, dated October 2026.
- The most recent is Delix Therapeutics' $100.0M Series C on 9 November 2026.
- Alumni Ventures is an investor in 46 of them, more than any other fund.
- Software is the most common sector, with 234 companies (77%).
- 43% were founded in 2020 or later; the median founding year is 2019.
- The most common team size is 11 to 50 employees (51% of companies with a recorded size).
- 11 are unicorns, valued at $1 billion or more.
Source: FundingWatcher. Data as of 16 November 2026. "Last 12 months" is the 365 days to that date.
Newest rounds
30 of 302| Company | What they do | Sector | Location | Last round | Amount | Date | Total raised | Investors | Employees | Founded |
|---|---|---|---|---|---|---|---|---|---|---|
| Delix Therapeutics | Delix Therapeutics develops psychoplastogen therapies that promote neuroplasticity. | Biotech | Boston, United States | Series C | $100.0M | 2026-11-09 | $244.1M | Gaingels, RA Capital Management, Dolby Family Ventures +2 | 11 to 50 | 2019 |
| Ocient | Ocient analyzes petabyte to exabyte scale data sets for organizations. | Hardware | Chicago, United States | Series C | $100.0M | 2026-11-05 | $256.5M | Alumni Ventures, Bossa Invest, Gaingels +1 | 101 to 250 | 2016 |
| Xona | Xona provides satellite navigation services that deliver positioning, navigation, and timing data from a low Earth orbit network. | Hardware | Burlingame, United States | Series D | $250.0M | 2026-10-22 | $582.1M | Gaingels, National Science Foundation, Creative Destruction Lab +2 | 101 to 250 | 2019 |
| Modal Labs | Modal Labs provides serverless cloud infrastructure for running machine learning and data processing workloads. | Artificial intelligence | New York, United States | Series D | $750.0M | 2026-10-14 | $1.2B | Gaingels, Creandum, The New Normal Fund | 251 to 500 | 2021 |
| Suki | Suki builds AI tools that help clinicians with clinical documentation and administrative tasks. | Artificial intelligence | Redwood City, United States | Series E | $90.0M | 2026-10-12 | $255.0M | Gaingels, First Round Capital, Breyer Capital +2 | 251 to 500 | 2017 |
| Mermaid Chart | Mermaid Chart offers smart diagramming software that lets enterprise teams create and share diagrams from text. | Software | San Francisco, United States | Series A | $7.6M | 2026-09-30 | $9.6M | Sequoia Capital, Gaingels, M12 - Microsoft's Venture Fund +2 | 11 to 50 | 2022 |
| BigHat Biosciences | BigHat Biosciences develops antibody and protein therapeutics using machine learning and automated experimentation. | Artificial intelligence | San Mateo, United States | Series C | $75.0M | 2026-09-24 | $174.3M | Andreessen Horowitz, Gaingels, 8VC +2 | 51 to 100 | 2019 |
| CivilGrid | CivilGrid provides pre-construction data platforms for engineering and construction teams. | Artificial intelligence | San Francisco, United States | Series A | $26.0M | 2026-08-27 | $28.2M | Gaingels, Afore Capital, Four Cities Capital +1 | 11 to 50 | 2020 |
| dili | Dili provides AI-powered compliance automation software for construction, infrastructure, and energy projects. | Artificial intelligence | New York, United States | Series A | $15.0M | 2026-07-30 | $21.8M | Y Combinator, Gaingels, Pioneer Fund +2 | 51 to 100 | 2023 |
| Latus Bio | Latus Bio develops gene therapies for central nervous system disorders using screened AAV capsids. | Biotech | Philadelphia, United States | Series A | $43.0M | 2026-05-04 | $97.0M | Gaingels, 8VC, Ben Franklin Technology Partners +1 | 11 to 50 | 2022 |
| Debbie | Debbie is a mobile platform that rewards consumers for reaching financial goals. | Fintech | New York, United States | Seed | $5.3M | 2026-04-13 | $10.6M | Liquid 2 Ventures, Gaingels, One Way Ventures +2 | 1 to 10 | 2021 |
| PeakMetrics | PeakMetrics tracks how online narratives form, spread, and influence public perception in real time. | Artificial intelligence | Los Angeles, United States | Series A | $6.0M | 2026-04-09 | $11.7M | Techstars, Gaingels, Gutbrain Ventures +2 | 11 to 50 | 2017 |
| Patlytics | Patlytics provides AI-driven patent intelligence tools for research and efficiency. | Artificial intelligence | New York, United States | Series B | $40.5M | 2026-04-08 | $66.1M | Alumni Ventures, Gaingels, 8VC +2 | 51 to 100 | 2024 |
| Gilgamesh Pharmaceuticals | Gilgamesh Pharmaceuticals is a clinical-stage biotechnology company developing psychedelic drugs to treat mental illness. | Biotech | New York, United States | Series A | $60.0M | 2026-03-24 | $142.6M | Y Combinator, Alumni Ventures, Gaingels +2 | 11 to 50 | 2019 |
| Bump | Bump is an AI-driven analytics platform that helps creators receive and manage microadvances for their businesses. | Artificial intelligence | Los Angeles, United States | Seed | $180K | 2026-03-01 | $4.7M | Plug and Play, Gaingels, Expert Dojo | 11 to 50 | 2020 |
| Circadian Risk | Circadian Risk provides physical security risk assessment software to protect people and critical assets. | Cybersecurity | Ann Arbor, United States | Series A | $6.0M | 2026-02-24 | $9.7M | Newchip Accelerator, Gaingels, Michigan Angel Fund | 1 to 10 | 2016 |
| Pepper | Pepper provides an AI-powered eCommerce platform for food distributors and suppliers to manage orders and customers. | Artificial intelligence | New York, United States | Series C | $50.0M | 2026-02-20 | $100.0M | Bossa Invest, Gaingels, Index Ventures +2 | 101 to 250 | 2019 |
| Varo Bank Unicorn | Varo Bank offers digital banking services with a focus on inclusive design. | Fintech | San Francisco, United States | Series G | $123.9M | 2026-02-02 | $1.2B | Gaingels, BlackRock, Warburg Pincus +2 | 501 to 1,000 | 2015 |
| GrubMarket Unicorn | GrubMarket operates a B2B eCommerce marketplace for the American food supply chain. | Artificial intelligence | San Francisco, United States | Series H | $50.0M | 2026-02-02 | $599.1M | Y Combinator, Alumni Ventures, Gaingels +2 | 1,001 to 5,000 | 2014 |
| Emobi | Emobi designs, manufactures, and markets zero-emission urban electric vehicles. | Artificial intelligence | San Francisco, United States | Seed | $3.4M | 2026-01-28 | $4.5M | Y Combinator, Gaingels, Goodwater Capital +2 | 11 to 50 | 2020 |
| Neurophos | Neurophos develops photonic hardware that accelerates artificial intelligence inference. | Artificial intelligence | Austin, United States | Series A | $110.0M | 2026-01-22 | $126.1M | Gaingels, Trajectory Ventures, Mana Ventures +1 | 11 to 50 | 2020 |
| Cambium | Cambium develops advanced materials for defense and aerospace using AI-driven designs. | Energy | El Segundo, United States | Series B | $100.0M | 2026-01-05 | $127.0M | Gaingels, 8VC, Susa Ventures | 101 to 250 | 2019 |
| Polygraf | Polygraf provides locally deployed, explainable, and auditable small language models for AI security. | Artificial intelligence | Austin, United States | Seed | $9.5M | 2025-10-28 | $11.9M | Gaingels, Sputnik ATX, 10X Capital +2 | 11 to 50 | 2023 |
| Gameto | Gameto develops cell-engineered therapeutics for the female reproductive system. | Biotech | New York, United States | Series C | $44.0M | 2025-08-12 | $117.0M | FJ Labs, Insight Partners, Gaingels +2 | 11 to 50 | 2020 |
| Qualytics | Qualytics automates data quality checks so companies can trust their data and get AI-ready. | Software | Atlanta, United States | Series A | $10.0M | 2025-06-23 | $16.7M | Gaingels, SaaS Ventures, Knoll Ventures +2 | 11 to 50 | 2020 |
| Jupe | Jupe provides well-appointed shelters that hospitality businesses use to enhance experiential offerings. | Energy | Newport Beach, United States | Seed | $1.1M | 2025-04-01 | $15.6M | Y Combinator, Gaingels, Soma Capital +1 | 11 to 50 | 2020 |
| Mast Reforestation | Mast Reforestation provides seedlings, project management, and carbon removal credits for forest restoration. | Energy | Seattle, United States | Series B | $25.0M | 2025-02-11 | $83.9M | Techstars, Bossa Invest, Right Side Capital Management +2 | 51 to 100 | 2016 |
| TaxGPT | TaxGPT uses artificial intelligence and tax information to automate tax filing. | Artificial intelligence | San Francisco, United States | Seed | $4.6M | 2025-02-06 | $5.1M | Y Combinator, Gaingels, LAUNCH +1 | 11 to 50 | 2023 |
| Paxton | Paxton is a legal technology firm that develops software for the legal industry. | Artificial intelligence | Palo Alto, United States | Series A | $22.0M | 2025-01-29 | $28.0M | Plug and Play, Gaingels, Unusual Ventures +2 | 11 to 50 | 2023 |
| 1up | 1up helps sales teams answer customer questions and complete RFPs and DDQs quickly. | Artificial intelligence | New York, United States | Seed | $5.2M | 2025-01-22 | $8.6M | Alumni Ventures, Gaingels, RRE Ventures +2 | 11 to 50 | 2024 |
Table 1. Gaingels portfolio companies: the 30 newest rounds whose row carries a description, a city, a named fund and an amount. Source: FundingWatcher. Data as of 16 November 2026. Base: 302.
Largest rounds
Last 12 months| # | Company | What they do | Sector | Location | Last round | Amount | Date | Total raised | Investors | Employees | Founded |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Modal Labs | Modal Labs provides serverless cloud infrastructure for running machine learning and data processing workloads. | Artificial intelligence | New York, United States | Series D | $750.0M | 2026-10-14 | $1.2B | Gaingels, Creandum, The New Normal Fund | 251 to 500 | 2021 |
| 2 | Xona | Xona provides satellite navigation services that deliver positioning, navigation, and timing data from a low Earth orbit network. | Hardware | Burlingame, United States | Series D | $250.0M | 2026-10-22 | $582.1M | Gaingels, National Science Foundation, Creative Destruction Lab +2 | 101 to 250 | 2019 |
| 3 | Varo Bank Unicorn | Varo Bank offers digital banking services with a focus on inclusive design. | Fintech | San Francisco, United States | Series G | $123.9M | 2026-02-02 | $1.2B | Gaingels, BlackRock, Warburg Pincus +2 | 501 to 1,000 | 2015 |
| 4 | Neurophos | Neurophos develops photonic hardware that accelerates artificial intelligence inference. | Artificial intelligence | Austin, United States | Series A | $110.0M | 2026-01-22 | $126.1M | Gaingels, Trajectory Ventures, Mana Ventures +1 | 11 to 50 | 2020 |
| 5 | Delix Therapeutics | Delix Therapeutics develops psychoplastogen therapies that promote neuroplasticity. | Biotech | Boston, United States | Series C | $100.0M | 2026-11-09 | $244.1M | Gaingels, RA Capital Management, Dolby Family Ventures +2 | 11 to 50 | 2019 |
| 6 | Ocient | Ocient analyzes petabyte to exabyte scale data sets for organizations. | Hardware | Chicago, United States | Series C | $100.0M | 2026-11-05 | $256.5M | Alumni Ventures, Bossa Invest, Gaingels +1 | 101 to 250 | 2016 |
| 7 | Cambium | Cambium develops advanced materials for defense and aerospace using AI-driven designs. | Energy | El Segundo, United States | Series B | $100.0M | 2026-01-05 | $127.0M | Gaingels, 8VC, Susa Ventures | 101 to 250 | 2019 |
| 8 | Suki | Suki builds AI tools that help clinicians with clinical documentation and administrative tasks. | Artificial intelligence | Redwood City, United States | Series E | $90.0M | 2026-10-12 | $255.0M | Gaingels, First Round Capital, Breyer Capital +2 | 251 to 500 | 2017 |
| 9 | BigHat Biosciences | BigHat Biosciences develops antibody and protein therapeutics using machine learning and automated experimentation. | Artificial intelligence | San Mateo, United States | Series C | $75.0M | 2026-09-24 | $174.3M | Andreessen Horowitz, Gaingels, 8VC +2 | 51 to 100 | 2019 |
| 10 | Gilgamesh Pharmaceuticals | Gilgamesh Pharmaceuticals is a clinical-stage biotechnology company developing psychedelic drugs to treat mental illness. | Biotech | New York, United States | Series A | $60.0M | 2026-03-24 | $142.6M | Y Combinator, Alumni Ventures, Gaingels +2 | 11 to 50 | 2019 |
Table 2. Gaingels portfolio companies: the 10 largest rounds of the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Most active investors
By companies backed| # | Investor | Type | Location | Companies | Share | Funded, 12 months | Latest |
|---|---|---|---|---|---|---|---|
| 1 | Alumni Ventures | Angel group | Manchester, United States | 46 | 15% | 5 | Ocient, Spaceium, Patlytics |
| 2 | Y Combinator | Startup accelerator | Mountain View, United States | 26 | 9% | 5 | dili, Spaceium, Gilgamesh Pharmaceuticals |
| 3 | Bossa Invest | Venture capital firm | São Paulo, Brazil | 25 | 8% | 2 | Ocient, Pepper |
| 4 | 8VC | Venture capital firm | Austin, United States | 10 | 3% | 4 | BigHat Biosciences, Latus Bio, Patlytics |
| 5 | Techstars | Startup accelerator | New York, United States | 10 | 3% | 1 | PeakMetrics |
| 6 | Pareto Holdings | Venture capital firm | New York, United States | 10 | 3% | ||
| 7 | Accel | Venture capital firm | Palo Alto, United States | 9 | 3% | ||
| 8 | Plug and Play | Startup accelerator | Sunnyvale, United States | 9 | 3% | 1 | Bump |
| 9 | Sequoia Capital | Venture capital firm | Menlo Park, United States | 9 | 3% | 1 | Mermaid Chart |
| 10 | FJ Labs | Micro VC fund | New York, United States | 8 | 3% | ||
| 11 | 500 Global | Startup accelerator | Palo Alto, United States | 8 | 3% | ||
| 12 | Soma Capital | Venture capital firm | San Francisco, United States | 8 | 3% | ||
| 13 | Liquid 2 Ventures | Venture capital firm | San Francisco, United States | 7 | 2% | 1 | Debbie |
| 14 | Mana Ventures | Venture capital firm | San Francisco, United States | 7 | 2% | 1 | Neurophos |
| 15 | General Catalyst | Venture capital firm | San Francisco, United States | 7 | 2% |
Table 3. Gaingels portfolio companies: the funds recorded as investors in the most companies. Latest: companies they back that raised in the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Sectors
| Sectors | Companies | Share | Total raised |
|---|---|---|---|
| Software | 234 | 77% | $11.2B |
| Artificial intelligence | 83 | 27% | $4.5B |
| Fintech | 75 | 25% | $4.7B |
| Health care | 40 | 13% | $2.2B |
| Commerce | 37 | 12% | $1.5B |
| Hardware | 27 | 9% | $2.0B |
| Cybersecurity | 24 | 8% | $1.1B |
| Biotech | 12 | 4% | $1.4B |
| Education | 11 | 4% | $316.4M |
| Energy | 6 | 2% | $277.7M |
Table 4. Gaingels portfolio companies by sector. Source: FundingWatcher. Data as of 16 November 2026.
Funding stage
Table 5. Gaingels portfolio companies by stage of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.
Countries
| Countries | Companies | Share |
|---|---|---|
| United States | 283 | 94% |
| Canada | 4 | 1% |
| Mexico | 4 | 1% |
| France | 2 | 1% |
| The Netherlands | 1 | 0% |
| Germany | 1 | 0% |
| Israel | 1 | 0% |
| Sweden | 1 | 0% |
| United Kingdom | 1 | 0% |
| Colombia | 1 | 0% |
| Gibraltar | 1 | 0% |
| Luxembourg | 1 | 0% |
Table 6. Gaingels portfolio companies by headquarters country. Source: FundingWatcher. Data as of 16 November 2026.
Cities
| Cities | Companies | Share |
|---|---|---|
| San Francisco | 68 | 23% |
| New York | 61 | 20% |
| Los Angeles | 26 | 9% |
| Palo Alto | 11 | 4% |
| Miami | 9 | 3% |
| Boston | 7 | 2% |
| Austin | 6 | 2% |
| Atlanta | 5 | 2% |
| Washington | 5 | 2% |
| San Mateo | 4 | 1% |
| Santa Monica | 4 | 1% |
| Chicago | 3 | 1% |
Table 7. Gaingels portfolio companies by headquarters city. Source: FundingWatcher. Data as of 16 November 2026.
Rounds by month
| Rounds by month | Companies | Share | Raised |
|---|---|---|---|
| November 2026 | 2 | 8% | $200.0M |
| October 2026 | 3 | 12% | $1.1B |
| September 2026 | 2 | 8% | $82.6M |
| August 2026 | 1 | 4% | $26.0M |
| July 2026 | 1 | 4% | $15.0M |
| June 2026 | 2 | 8% | $11.8M |
| May 2026 | 1 | 4% | $43.0M |
| April 2026 | 3 | 12% | $51.8M |
| March 2026 | 2 | 8% | $60.2M |
| February 2026 | 4 | 17% | $229.9M |
| January 2026 | 3 | 12% | $213.4M |
Table 8. Gaingels portfolio companies: most recent round by month, last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Most recent round by year
| Most recent round by year | Companies | Share | Raised |
|---|---|---|---|
| 2026 | 24 | 8% | $2.0B |
| 2025 | 20 | 7% | $357.9M |
| 2024 | 57 | 19% | $738.7M |
| 2023 | 58 | 19% | $289.0M |
| 2022 | 84 | 28% | $2.0B |
| 2021 | 42 | 14% | $1.8B |
Table 9. Gaingels portfolio companies by year of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.
Founding year
| Founding year | Companies | Share |
|---|---|---|
| 2023 or later | 18 | 6% |
| 2020 to 2022 | 110 | 37% |
| 2015 to 2019 | 150 | 50% |
| 2010 to 2014 | 22 | 7% |
| Before 2010 | 1 | 0% |
Table 10. Gaingels portfolio companies by founding year. Source: FundingWatcher. Data as of 16 November 2026.
Team size
| Team size | Companies | Share |
|---|---|---|
| 1 to 10 | 57 | 19% |
| 11 to 50 | 154 | 51% |
| 51 to 100 | 47 | 16% |
| 101 to 250 | 34 | 11% |
| 251 to 500 | 6 | 2% |
| 501 to 1,000 | 2 | 1% |
| 1,001 to 5,000 | 2 | 1% |
Table 11. Gaingels portfolio companies by headcount. Source: FundingWatcher. Data as of 16 November 2026.
Method
- A company is on this list when Gaingels is recorded as one of its investors. On 16 November 2026 that is 302 companies.
- Stage, round, amount and date are those of the company's most recent funding round. Amounts are in US dollars as the source records them.
- The table prints the 30 newest rounds whose row is complete: a one-sentence description, a city, a named fund and an amount. The CSV carries all 302 rows: 37 have no round amount, 0 no city and 11 no website. The CSV carries domain, website, LinkedIn and the cached description sentence where present.
Sources, fields and exclusions of both files: Method.
Questions
- How many Gaingels portfolio companies are on the list?
- 302, in the file dated 16 November 2026. 24 of them closed their most recent round in the last 12 months.
- What does the CSV contain?
- One row per company, 18 columns: name, domain, website, linkedin, description, founded, employees, city, region, country, sectors, funding_stage, last_round, last_round_date, last_round_usd, total_raised_usd, rounds, investors.
- How much does the list cost?
- $29 one-time for all 302 rows, no account. Every investor and every startup, two files, cost $99. With founder contacts, up to 2 founders or CEOs per company compiled to order and mailed within 24 hours, $199.
- What arrives after payment?
- At once: the CSV download link, on the page after payment and by mail.
- Can I see rows before buying?
- The 3 rows under the buy button are rows of the CSV with every column. The form below it mails 10 rows.
- How current is the data?
- The file is dated 16 November 2026. The download link serves the current file each time it is opened.
Not sure about the data?
Download a free 10-row sample first. No account, no payment.